Thermo Fisher Scientific ($TMO) has confirmed its Kinetica software will generate inaccurate results when analyzing unbalanced clinical trials, Reuters reports. The company thinks the glitch is unlikely to have caused significant discrepancies and it expects to fix the problem by updating the software within 8 weeks. Article